| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A break-even price calculation for the use of sirolimus-eluting stents in angioplasty
|
Galanaud, Jean-Philippe
|
|
2003
|
25 |
3 |
p. 1007-1016
10 p.
|
artikel
|
| 2 |
A randomized, double-blind, parallel-group comparison of olopatadine 0.1% ophthalmic solution versus placebo for controlling the signs and symptoms of seasonal allergic conjuctivitis and rhinoconjunctivitis
|
Abelson, Mark B
|
|
2003
|
25 |
3 |
p. 931-947
17 p.
|
artikel
|
| 3 |
A rationale for the use of summary measurements for the assessment of the effects of rheumatoid arthritis therapies
|
Schiff, Michael
|
|
2003
|
25 |
3 |
p. 993-1001
9 p.
|
artikel
|
| 4 |
Comparison of treatment with fluvastatin extended-release 80-mg tablets and immediate-release 40-mg capsules in patients with primary hypercholesterolemia
|
Isaacsohn, Jonathan L.
|
|
2003
|
25 |
3 |
p. 904-918
15 p.
|
artikel
|
| 5 |
Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia
|
Wunderink, Richard G
|
|
2003
|
25 |
3 |
p. 980-992
13 p.
|
artikel
|
| 6 |
Corrections
|
|
|
2003
|
25 |
3 |
p. 1039-
1 p.
|
artikel
|
| 7 |
Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000
|
O'Brien, Judith A.
|
|
2003
|
25 |
3 |
p. 1017-1038
22 p.
|
artikel
|
| 8 |
Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma
|
Corren, Jonathan
|
|
2003
|
25 |
3 |
p. 776-798
23 p.
|
artikel
|
| 9 |
Glimerpiride in type 2 diabetes mellitus: A review of the worldwide therapeutic experience
|
Massi-Benedetti, Massimo
|
|
2003
|
25 |
3 |
p. 799-816
18 p.
|
artikel
|
| 10 |
Inhibition of leukotriene biosynthesis by a novel dietary fatty acid formulation in patients with atopic asthma: A randomized, placebo-controlled, parallel-group, prospective trial
|
Surette, Marc E.
|
|
2003
|
25 |
3 |
p. 972-979
8 p.
|
artikel
|
| 11 |
Inhibition of leukotriene synthesis, pharmacokinetics, and tolerability of a novel dietary fatty acid formulation in healthy adult subjects
|
Surette, Marc E.
|
|
2003
|
25 |
3 |
p. 948-971
24 p.
|
artikel
|
| 12 |
Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea
|
Goldstein, Barry J.
|
|
2003
|
25 |
3 |
p. 890-903
14 p.
|
artikel
|
| 13 |
Post hoc analysis of data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial on the effects of three years of raloxifene treatment on glycemic control and cardiovascular disease risk factors in women with and without type 2 diabetes
|
Barrett-Connor, Elizabeth
|
|
2003
|
25 |
3 |
p. 919-930
12 p.
|
artikel
|
| 14 |
Standards and certification to recognize pharmacoeconomics as a profession
|
Lyles, Alan
|
|
2003
|
25 |
3 |
p. 1004-1006
3 p.
|
artikel
|
| 15 |
The use of gabapentin for the treatment of postherpetic neuralgia
|
Singh, Devada
|
|
2003
|
25 |
3 |
p. 852-889
38 p.
|
artikel
|
| 16 |
Trandolapril: A newer angiotensin-converting enzyme inhibitor
|
Guay, David R.P.
|
|
2003
|
25 |
3 |
p. 713-775
63 p.
|
artikel
|
| 17 |
Valdecoxib: A review
|
Chavez, Mary L.
|
|
2003
|
25 |
3 |
p. 817-851
35 p.
|
artikel
|
Tijdschrift beschrijving